Patients with more advanced TNM stage, infiltration depth, and lymph node metastasis had increased serum COX-2, AQP1, and G-17 levels and decreased PG-I levels (P<0.05). Here, PTGS2 is linked to metastatic malignant neoplasm in the lymph nodes.